Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunoglobulin A”

4,714 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,714 results

Early research (Phase 1)Ended earlyNCT00351325
What this trial is testing

BMS-663513 Administered in Combination With Chemotherapy to Subjects With Advanced Solid Malignancies

Who this might be right for
Advanced Solid Malignancies
Bristol-Myers Squibb 45
Not applicableActive Not RecruitingNCT06767020
What this trial is testing

Comparative Study on AQP4 Antibody Detection Methods

Who this might be right for
NMOSD
First Affiliated Hospital of Chongqing Medical University 120
Testing effectiveness (Phase 2)Study completedNCT00048555
What this trial is testing

Safety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Biogen 90
Testing effectiveness (Phase 2)Study completedNCT04667910
What this trial is testing

601 Versus Ranibizumab in Patients With Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Central Retinal Vein Occlusion
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 60
Not applicableStudy completedNCT03728062
What this trial is testing

Mindfulness Meditation Versus Physical Exercise: Comparing Effects on Stress and Immunocompetence

Who this might be right for
StressHealth Knowledge, Attitudes, Practice
Universidad Nacional de Educación a Distancia 72
Early research (Phase 1)Study completedNCT03744403
What this trial is testing

CS1001 in Subjects with Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
CStone Pharmaceuticals 24
Testing effectiveness (Phase 2)Study completedNCT01016015
What this trial is testing

Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone Sarcoma

Who this might be right for
Metastatic OsteosarcomaRecurrent Adult Soft Tissue SarcomaRecurrent Osteosarcoma+2 more
National Cancer Institute (NCI) 178
Large-scale testing (Phase 3)Study completedNCT00049517
What this trial is testing

Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia

Who this might be right for
Leukemia
Eastern Cooperative Oncology Group 657
Early research (Phase 1)Active Not RecruitingNCT03283917
What this trial is testing

Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis

Who this might be right for
Newly Diagnosed Primary AmyloidosisRecurrent Primary AmyloidosisRefractory Primary Amyloidosis
M.D. Anderson Cancer Center 21
Early research (Phase 1)Study completedNCT01969643
What this trial is testing

A Safety Study of SGN-LIV1A in Breast Cancer Patients

Who this might be right for
HER2 Positive Breast NeoplasmsHormone Receptor Positive Breast NeoplasmsTriple Negative Breast Neoplasms+1 more
Seagen Inc. 290
Early research (Phase 1)Looking for participantsNCT05652335
What this trial is testing

JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

Who this might be right for
Relapsed or Refractory Multiple MyelomaPreviously Treated Amyloid Light-chain (AL) Amyloidosis
Janssen Research & Development, LLC 180
Large-scale testing (Phase 3)Looking for participantsNCT06170489
What this trial is testing

A Phase III Clinical Study Comparing JS004 Plus Toripalimab With Investigator-Selected Chemotherapy in Patients With PD-(L)1monoclonal Antibody Refractory Classic Hodgkin Lymphoma (cHL)

Who this might be right for
Hodgkin Lymphoma
Shanghai Junshi Bioscience Co., Ltd. 185
Early research (Phase 1)Study completedNCT02216890
What this trial is testing

Safety Study of SGN-CD70A in Cancer Patients

Who this might be right for
Renal Cell CarcinomaMantle-Cell LymphomaDiffuse, Large B-Cell, Lymphoma+1 more
Seagen Inc. 38
Early research (Phase 1)Ended earlyNCT03936959
What this trial is testing

LY3434172, a PD-1 and PD-L1 Bispecific Antibody, in Advanced Cancer

Who this might be right for
Advanced Cancer
Eli Lilly and Company 10
Not applicableStudy completedNCT04741386
What this trial is testing

The REnal Patients COVID-19 VACcination Immune Response (RECOVAC IR) Study

Who this might be right for
Covid19Chronic Kidney Diseases
University Medical Center Groningen 854
Post-approval studies (Phase 4)Study completedNCT00144768
What this trial is testing

A Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG (Glycosaminoglycan) Levels in Aldurazyme® Treated Patients

Who this might be right for
Mucopolysaccharidosis IHurler's SyndromeHurler-Scheie Syndrome+1 more
Genzyme, a Sanofi Company 25
Not applicableStudy completedNCT03459482
What this trial is testing

Endpoint Determination Study Protocol

Who this might be right for
Irritable Bowel Syndrome
Biomerica 556
Testing effectiveness (Phase 2)Study completedNCT00722046
What this trial is testing

Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 198
Large-scale testing (Phase 3)Study completedNCT00121108
What this trial is testing

MEDI-524 (Motavizumab) for the Prevention of Respiratory Sycytial Virus (RSV) Disease Among Native American Indian Infants in the Southwestern United States

Who this might be right for
Healthy
MedImmune LLC 2,127
Testing effectiveness (Phase 2)WithdrawnNCT06545617
What this trial is testing

A Clinical Study to Observe How Well That BAT8006 Works on Patients With Platinum Resistance Ovarian Cancer

Who this might be right for
Platinum-resistant Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Bio-Thera Solutions
Load More Results